COMMUNIQUÉS West-GlobeNewswire

Precision Imaging Centers Implements eRAD RIS, Portals, and RADAR
12/02/2018
GREENVILLE, S.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- eRAD, a subsidiary of RadNet, Inc., a leading provider of standards-based, web-centric radiology image and data management solutions, announced today that Precision [...]
PRA Health Sciences Partners with IMPACT2030
12/02/2018
RALEIGH, N.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH ) is pleased to announce that it has joined IMPACT2030 as a collaborating partner. IMPACT2030 is a coalition of businesses working [...]
Remedy Pharmaceuticals Co-founder and CEO Brings Clinical Trial and Company-Building Experience to ReNetX Bio Advisory Board
12/02/2018
NEW HAVEN, Conn., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Sven Jacobson will be the first to admit that developing a new therapeutic for spinal cord injury is a challenging road. But the latest member of the ReNetX Advisory [...]
Anti-Aging Patent Application Filed; Exclusive Commercial Rights to Premier Biomedical, Inc.
12/02/2018
JACKSON CENTER, Pa., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced today the filing of a patent application, “Method For Slowing The Aging Process”, by Mitchel S. Felder, MD, the [...]
Endonovo Reports Positive Results in Critical Limb Ischemia Study Using Non-Invasive Medical Device
12/02/2018
LOS ANGELES, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of non-invasive wearable Electroceutical™ devices, today announced [...]
Merit Medical Systems to Announce Fourth Quarter and Year End Results on February 28, 2018
12/02/2018
SOUTH JORDAN, Utah, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI ), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and [...]
BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102
12/02/2018
505(b)(2) application plan acceptable per FDA Application will seek dual indications for opioid and alcohol use disorders ANAHEIM, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a [...]
Advantis Corp. Unexpectedly Set To Triple California Amster-Can Revenue by End of 2nd Quarter
12/02/2018
NEWPORT BEACH, CA, Feb. 12, 2018 (GLOBE NEWSWIRE) -- ADVANTIS CORPORATION (OTC PINK: ADVT) is currently working with new and existing partners to more than triple the total California Amster-Can canning production. Two [...]
Avadel Pharmaceuticals Announces Divestiture of Pediatric Business
12/02/2018
Cerecor to acquire Avadel’s pediatric assets Enters into license agreement to develop four LiquiTime ™ or Micropump ® products DUBLIN, Ireland, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ: AVDL [...]
DBV Technologies présente de nouveaux résultats lors du Congrès Annuel 2018 de l'AAAAI/WAO concernant sa plateforme Viaskin
12/02/2018
Communiqué de presse Montrouge, France, le 12 février 2018 (15h00 CET) DBV Technologies présente de nouveaux résultats lors du Congrès Annuel 2018 de l'AAAAI/WAO concernant sa plateforme Viaskin DBV Technologies ( [...]
DBV Technologies to Highlight Viaskin Technology Platform at the 2018 AAAAI/WAO Joint Congress
12/02/2018
Press Release Montrouge, France, February 12, 2018 DBV Technologies to Highlight Viaskin Technology Platform at the 2018 AAAAI/WAO Joint Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock [...]
Children’s National Health System Selects Artifact Health Mobile Query Platform to Streamline Physician Query Process
12/02/2018
BOULDER, Colo., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Artifact Health , which provides the first and only mobile app that streamlines the physician query process, announced today that Children’s National Health System , [...]
Adamis Pharmaceuticals Announces FDA Acceptance for Review for the Supplemental New Drug Application of Its Low Dose Symjepi Product Candidate
12/02/2018
SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP ) (“Company” or “Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has accepted for review the [...]
Cognition Therapeutics to Participate in Leerink Partners 7th Annual Global Healthcare Conference
12/02/2018
PITTSBURGH, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., a clinical stage neuroscience company focused on the development of innovative therapeutics for the treatment of Alzheimer’s disease and other [...]
Interpace Diagnostics to Present Data on Thyroid, Pancreatic, and Lung Assays
12/02/2018
PARSIPPANY, N.J., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG ) (“Interpace” or “the Company”), a fully integrated commercial and bioinformatics company that provides clinically [...]
Trading in Novo Nordisk shares by board members, executives and associated persons on 10 February 2018
12/02/2018
Bagsværd, Denmark, 12 February 2018 - This document discloses the data of the transaction(s) made in Novo Nordisk shares by the company's board members, executives and their associated persons in accordance with Article [...]
Novo Nordisk A/S - Share repurchase programme
12/02/2018
Bagsværd, Denmark, 12 February 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]
Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-202 Gene Therapy Program in Infantile Batten Disease
12/02/2018
NEW YORK and CLEVELAND, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]
Abattis awarded a Mitacs grant for R&D of nanoemulsified cannabinoid-rich hemp oil in conjunction with food scientists from the University of British Columbia
12/02/2018
VANCOUVER, British Columbia, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce the sponsorship of a research study in partnership with [...]

Pages